Skip to main content
. 2016 Oct 26;7(49):80262–80274. doi: 10.18632/oncotarget.12918

Figure 10. Illustration for the mechanism underlying Andrographolide for improvement of OVA-induced lung inflammation in mice.

Figure 10

Andrographolide ameliorates OVA-induced lung injury in mice by suppressing ROS-mediated NF-κB signaling and NLRP3 inflammasome activation.